Low-Dose Mitomycin-C for Mucosal Overgrowth Treatment in Boston Type 1 Keratoprosthesis With Autologous Buccal Mucosa Overlay in a Patient With Severe Stevens-Johnson Syndrome.

Pastor Asensio A, Pons-Talaya C, Andino Angulo C, Julio Morán G, Barbany Rodríguez M, Barraquer Compte RI

Open source

DOI
10.1097/ico.0000000000004283
Published
2026 Aug 31
Container
Cornea
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/ico.0000000000004283,
  title = {Low-Dose Mitomycin-C for Mucosal Overgrowth Treatment in Boston Type 1 Keratoprosthesis With Autologous Buccal Mucosa Overlay in a Patient With Severe Stevens-Johnson Syndrome.},
  author = {Pastor Asensio A and Pons-Talaya C and Andino Angulo C and Julio Morán G and Barbany Rodríguez M and Barraquer Compte RI},
  year = {2026},
  journal = {Cornea},
  doi = {10.1097/ico.0000000000004283},
  url = {https://doi.org/10.1097/ico.0000000000004283}
}

RIS

TY  - JOUR
TI  - Low-Dose Mitomycin-C for Mucosal Overgrowth Treatment in Boston Type 1 Keratoprosthesis With Autologous Buccal Mucosa Overlay in a Patient With Severe Stevens-Johnson Syndrome.
AU  - Pastor Asensio A
AU  - Pons-Talaya C
AU  - Andino Angulo C
AU  - Julio Morán G
AU  - Barbany Rodríguez M
AU  - Barraquer Compte RI
PY  - 2026
JO  - Cornea
DO  - 10.1097/ico.0000000000004283
UR  - https://doi.org/10.1097/ico.0000000000004283
ER  - 

APA

A, P. A., C, P., C, A. A., G, J. M., M, B. R., & RI, B. C. (2026). Low-Dose Mitomycin-C for Mucosal Overgrowth Treatment in Boston Type 1 Keratoprosthesis With Autologous Buccal Mucosa Overlay in a Patient With Severe Stevens-Johnson Syndrome.. Cornea. https://doi.org/10.1097/ico.0000000000004283

Source records